e-SPACE Heart Failure 2023

Published: 25 October 2023

  • Views:

    Views Icon 3135

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure 2023.

 

A thoughtfully curated programme supported the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice and showed the latest information on patient profiling in heart failure for tailoring medical therapy.

 

This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.

 

Click here to watch e-SPACE Heart Failure 2022.
 

e-SPACE Heart Failure 2023 would like to thank the following sponsors:

Learning Objectives

  • Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
  • Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
  • Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
  • Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
  • Translate the findings of recent studies and guidelines into optimal patient management

Target Audience

  • Heart Failure Specialists
  • General Cardiologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Part 1

Day One

10 sessions
Plenary session 1 – Recent guideline updates in HF Watch now
Meet the expert – Iron Deficiency & IV Iron – The 2023 ESC HF Guidelines and Recent Trial Results: Interpretation & Implementation (Supported by an unrestricted educational grant from Pharmacosmos) Watch now
Plenary session 2 – GDMT in the clinical setting Watch now
Special Live Interactive Session – Management of ATTR-CM Watch now
Meet the expert – Best practices in the management of patients with cardiac amyloidosis (Supported by an educational grant from AstraZeneca) Watch now
Plenary session 3 – SGLT2i in clinical practice Watch now
Meet the expert – Management of patients with HFpEF: What did we learn from our HFrEF patients (Supported by an educational grant from AstraZeneca) Watch now
Plenary session 4 – Obesity and weight management in HF Watch now
Special Live Interactive Session – Best practices for hyperkalemia management across the cardiorenal spectrum Watch now
Plenary session 5 – Worsening and acute heart failure Watch now

Part 2

Day Two

8 sessions
Meet the expert – Iron deficiency and heart failure – what we have learnt so far? (Supported by an unrestricted educational grant from CSL Vifor) Watch now
Plenary session 6 – Iron deficiency: the totality of evidence Watch now
Meet the expert – Practical approaches in the management of hyperkalemia (Supported by an educational grant from AstraZeneca) Watch now
Plenary session 7 – Managing comorbidities in HF Watch now
Plenary session 8 – Devices in HF: time to reassess their place? Watch now
Meet the expert – What happens if you fix FMR, but ignore the root cause of heart failure? (Supported by an unrestricted educational grant from Cardiac Dimensions) Watch now
Plenary session 9 – New technologies for HF management Watch now
Plenary session 10 – Special Populations Watch now

Faculty Biographies

John GF Cleland

John GF Cleland

Professor of Cardiology

Prof John Cleland is a Professor of Cardiology at University of Glasgow, Glasgow, UK.

In 1977, he qualified from the University of Glasgow, completed training at St. Mary's & Hammersmith Hospitals (London) and was awarded a Senior Fellowship by the British Heart Foundation.

His main interests include heart failure, extending from epidemiology & prevention, to Phase II-IV trials and guidelines. 

He founded the European Journal of Heart Failure and is Past-Chair of the ESC Working Group on heart failure and British Society for Heart Failure.

 

 

 

View full profile
Lynne W Stevenson

Lynne W Stevenson

Professor of Medicine and Director of Cardiomyopathy Program

Dr Lynne Stevenson is a Professor of Medicine and Director of Cardiomyopathy Program at Vanderbilt University Medical Center, Nashville, US.

Her research experience includes acute and ambulatory hemodynamic monitoring, exercise physiology, heart failure hospitalisations and the interface of arrhythmias and sudden death risk with left ventricular dysfunction.

View full profile
Jasper J Brugts

Jasper J Brugts

Heart Failure Cardiologist

Dr Jasper J Brugts is a Heart Failure Cardiologist at Erasmus University Medical Centre, Rotterdam, NL.

He is also a clinical epidemiologist and clinical trialist.

View full profile
Dan Burkhoff

Dan Burkhoff

Director

Dr Dan Burkhoff is currently the Director of Heart Failure, Hemodynamics and MCS Research at Cardiovascular Research Foundation, New York, US. Dr Burkhoff's interest include cardiovascular modeling and ventricular mechanics, cardiovascular monitoring, heart failure, device and pharmacologic treatments for heart failure, including left ventricular assist devices. He is also author of Harvi, an interactive simulation-based application for teaching and researching on ventricular mechanics and hemodynamics.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.